Live attenuated F strain of Mycoplasma gallisepticum
Active immunization of layers in order to reduce mortality, clinical symptoms and infection with Mycoplasma gallisepticum (MG)
If you have any questions, please do not hesitate to contact us or send us an e-mail to contact.vn@ceva.com!
COMPOSITION
CEVAC® MG-F contains the live F strain of Mycoplasma gallisepticum attenuated and non-pathogenic for chicken in freeze-dried pellet.
DOSAGE AND ADMINISTRATION
CEVAC® MG-F is administered via occular/intranasal route.
One dose per animal.
CEVAC®MG-F is recommended to be administered to birds prior to field exposure and prior to the onset ofegg production, between 8 and 16 weeks of age.
Birds on farms with high risk of MG infestation should be vaccinated twice, with a priming vaccination between 6 and 10 weeks of age,followed by a booster vaccihation between 12 and 16 weeks of age, with an interval of at least 2 weeks within the two vaccinations.
SIDE EFFECT
Vaccination may induce mild respiratory signs which can persist for a few days.
Overdose = Mild respiratory reaction can be observed for few days after vaccination.
STORAGE
Store the vaccine between +2°C to +8°C (từ 35°F đến 45°F).
Protect from light
PACKAGE
500 - 1.000 and 2.000 dose vials
WARNING
Do not use in turkeys.
The use of antibiotics or other antibacterial substances with action on MG should be avoided from 7 days before vaccination to 7 days after vaccination.
FOR ANIMAL TREATMENT ONLY